Physiologically-Based Biopharmaceutics Modelling to Inform Drug Product Quality and Clinical Decisions

18 September 2023 09:45 - 10:15

  • Recent developments on application of PBPK/PBBM models to inform bioequivalence decisions
  • Linking dissolution to clinically relevant specifications
  • Use of PBPK modelling to understand food effect after formulation changes
  • Emerging use of PBPK modelling to understand excipient interactions

Filippos Kesisoglou, Distinguished Scientist, Pharmaceutical Sciences and Clinical Supply, Merck